Humana Inc Etf Current Valuation
| HUM Etf | USD 296.38 0.30 0.10% |
Valuation analysis of Humana Inc helps investors to measure Humana's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. Fundamental drivers impacting Humana's valuation include:
Price Book 2.0338 | Enterprise Value 43.6 B | Price Sales 0.3103 | Forward PE 17.2117 | Trailing PE 25.8847 |
Undervalued
Today
Please note that Humana's price fluctuation is very steady at this time. Calculation of the real value of Humana Inc is based on 3 months time horizon. Increasing Humana's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Humana etf is determined by what a typical buyer is willing to pay for full or partial control of Humana Inc. Since Humana is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Humana Etf. However, Humana's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 296.38 | Real 323.51 | Target 587.53 | Hype 298.45 | Naive 298.48 |
The intrinsic value of Humana's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Humana's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Humana Inc helps investors to forecast how Humana etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Humana more accurately as focusing exclusively on Humana's fundamentals will not take into account other important factors: Humana Inc ETF Current Valuation Analysis
Humana's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Humana Current Valuation | 43.63 B |
Most of Humana's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Humana Inc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Humana Inc has a Current Valuation of 43.63 B. This is much higher than that of the Health Care Providers & Services family and significantly higher than that of the Health Care category. The current valuation for all United States etfs is notably lower than that of the firm.
Humana Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Humana's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of Humana could also be used in its relative valuation, which is a method of valuing Humana by comparing valuation metrics of similar companies.Humana is currently under evaluation in current valuation as compared to similar ETFs.
Humana ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Humana's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Humana's managers, analysts, and investors.Environment Score | Governance Score | Social Score |
Humana Fundamentals
| Return On Equity | 0.0784 | ||||
| Return On Asset | 0.0401 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 43.63 B | ||||
| Shares Outstanding | 120.41 M | ||||
| Shares Owned By Insiders | 0.21 % | ||||
| Shares Owned By Institutions | 94.78 % | ||||
| Number Of Shares Shorted | 4.55 M | ||||
| Price To Earning | 19.12 X | ||||
| Price To Book | 2.03 X | ||||
| Price To Sales | 0.31 X | ||||
| Revenue | 106.37 B | ||||
| Gross Profit | 17.18 B | ||||
| EBITDA | 4.93 B | ||||
| Net Income | 2.49 B | ||||
| Cash And Equivalents | 5.06 B | ||||
| Cash Per Share | 143.73 X | ||||
| Total Debt | 11.66 B | ||||
| Debt To Equity | 0.85 % | ||||
| Current Ratio | 1.53 X | ||||
| Book Value Per Share | 145.88 X | ||||
| Cash Flow From Operations | 3.98 B | ||||
| Short Ratio | 1.93 X | ||||
| Earnings Per Share | 11.45 X | ||||
| Price To Earnings To Growth | 1.36 X | ||||
| Target Price | 288.15 | ||||
| Number Of Employees | 67.6 K | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 35.69 B | ||||
| Total Asset | 47.06 B | ||||
| Retained Earnings | 27.54 B | ||||
| Working Capital | 366.27 M | ||||
| Current Asset | 2.76 B | ||||
| Current Liabilities | 2.39 B | ||||
| Annual Yield | 0.01 % | ||||
| Five Year Return | 0.64 % | ||||
| Net Asset | 47.06 B | ||||
| Last Dividend Paid | 3.54 |
About Humana Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Humana Inc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Humana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Humana Inc based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Humana Etf
Humana financial ratios help investors to determine whether Humana Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Humana with respect to the benefits of owning Humana security.